The growing global burden of neuropsychiatric disorders is a critical driver for the treatment market. With over 9.1 million annual deaths attributed to neurological diseases and an additional 8 ...

Investing.com -- ATAI Life Sciences (NASDAQ: ATAI) stock surged 29% after the company and its partner Beckley Psytech announced positive topline results from a Phase 2b study of BPL-003 in patients ...

Depression and anxiety are the most common psychiatric disorders in the world. Around 300 million people suffer from ...